Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Treatment of gonarthrosis using autologous platelet-rich plasma

Egiazaryan KA, Danilov MA, Abdusalamov RM
About authors

Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Maxim A. Danilov
Ostrovityanova, 1, Moscow, 117997, Russia; moc.liamg@volinad.dm

About paper

Author contribution: Egiazaryan KA, Danilov MA — study design development, analysis of results; Danilov MA, Abdusalamov RM — data collection, literature review, preparation administration, assessment of the results.

Compliance with ethical standards: the study was approved by the Ethics Committee of the N.I. Pirogov Russian National Research Medical University (Minutes #213 of December 13, 2021).

Received: 2024-01-30 Accepted: 2024-03-02 Published online: 2024-04-19
|
Fig. 1. Initial pain intensity dynamics after over 30 minutes of rest, all groups, percentages. * — significance of differences (p < 0.05) between indicators of the control group and those registered for groups 1 and 2; * * — significance of differences (p < 0.001) between indicators of the control group and group 2
Fig. 2. Morning joint stiffness dynamics, all participants, percentages. * — significance of differences (p < 0.05) between indicators of the control group and those registered for groups 1 and 2; * * — significance of differences (p < 0.001) between indicators of the control group and groups 1 and 2
Fig. 3. Dynamics of the physical indicators of QOL, as registered with a SF-36 survey before treatment, 3 and 6 months thereafter. * — significance of differences (p < 0.05), indicator's value before and after treatment, intragroup; * * — significance of differences (p < 0.001), indicator's values, treatment group and comparison group, 3 and 6 months after treatment
Fig. 4. Dynamics of the mental indicators of QOL, as registered with a SF-36 survey before treatment, 3 and 6 months thereafter. * — significance of differences (p < 0.05) of the indicator values before and after treatment.
Fig. 5. Pain intensity, VAS registration, all patients (points). * — significance of differences (p < 0.05), indicator's value compared to control group; * * — significance of differences (p < 0.001), indicator's values, treatment group and comparison group compared
Table. Dynamics of ultrasonography indicators of the knee OA against the background of treatment, all patients
Note: * — significance of differences (p < 0.05) of the indicator values before and after treatment, intragroup.